Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor

Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor

Background. Circulating microRNAs are appealing biomarkers to monitor several processes underlying cardiovascular diseases. Platelets are a major source for circulating microRNAs. Interestingly, the levels of specific microRNAs were reported to correlate with the level of platelet activation. The ai...

Full description

Bibliographic Details
Main Authors:	Annarita Carino, Salvatore De Rosa, Sabato Sorrentino, Alberto Polimeni, Jolanda Sabatino, Gianluca Caiazzo, Daniele Torella, Carmen Spaccarotella, Annalisa Mongiardo, Antonio Strangio, Carol Filippis, Ciro Indolfi
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2016/3968206

Similar Items

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis
by: Alberto Polimeni, et al.
Published: (2020-02-01)

Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients
by: Alberto Polimeni, et al.
Published: (2021-05-01)

Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work
by: Jolanda Sabatino, et al.
Published: (2021-08-01)

Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study
by: Ciro Indolfi, et al.
Published: (2018-10-01)

Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
by: Ciro Indolfi, et al.
Published: (2021-08-01)

Non-invasive myocardial work is reduced during transient acute coronary occlusion.
by: Jolanda Sabatino, et al.
Published: (2020-01-01)

B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity—A Meta-Analysis
by: Sabato Sorrentino, et al.
Published: (2020-09-01)

Description and Validation of TAVIApp: A Novel Mobile Application for Support of Physicians in the Management of Aortic Stenosis—Management of Aortic Stenosis with TAVIApp
by: Ciro Indolfi, et al.
Published: (2017-01-01)

Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis.
by: Salvatore De Rosa, et al.
Published: (2020-01-01)

Reliability of Instantaneous Wave-Free Ratio (iFR) for the Evaluation of Left Main Coronary Artery Lesions
by: Salvatore De Rosa, et al.
Published: (2019-07-01)

Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal
by: Carmen Spaccarotella, et al.
Published: (2021-07-01)

Ticagrelor as an Alternative for Clopidogrel-Associated Acute Arthritis
by: Starr-Mar’ee C. Bedy, et al.
Published: (2018-01-01)

Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials
by: Sabato Sorrentino, et al.
Published: (2020-03-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of Treatment
by: Thomas O. Bergmeijer, et al.
Published: (2018-10-01)

Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
by: Nikita Lomakin, et al.
Published: (2019-12-01)

Measurement of the QT interval using the Apple Watch
by: Carmen Anna Maria Spaccarotella, et al.
Published: (2021-05-01)

Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis
by: Salvatore De Rosa, et al.
Published: (2017-09-01)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Bin YANG, et al.
Published: (2018-07-01)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
by: Aguiar, M.O, et al.
Published: (2022)

Empagliflozin prevents doxorubicin-induced myocardial dysfunction
by: Jolanda Sabatino, et al.
Published: (2020-05-01)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
by: Ying Yao, et al.
Published: (2019-10-01)

The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
by: Woong Gil Choi, et al.
Published: (2021-03-01)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
by: Yingying Yang, et al.
Published: (2020-06-01)

Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
by: Hyoung Woo Chang, et al.
Published: (2019-01-01)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
by: Grima DT, et al.
Published: (2014-01-01)

Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
by: Anastasiou, I., et al.
Published: (2022)

Common Calcified Femoral Artery Rupture After Intravascular Lithotripsy for TAVR Implantation
by: Carmen Spaccarotella, MD, et al.
Published: (2020-06-01)

A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study.
by: Benjamin Hibbert, et al.
Published: (2014-01-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
by: Dong Wang, et al.
Published: (2018-11-01)

Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding
by: Paolo Nardi, et al.
Published: (2020-01-01)

Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence
by: Viveka Kumar, et al.
Published: (2018-12-01)

Long-term cost-effectiveness of ticagrelor versus clopidogrel in acute coronary syndrome in Spain
by: E. Molina-Cuadrado, et al.
Published: (2014-07-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
by: Karla N. Samman, et al.
Published: (2021-06-01)

Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan
by: Chih-Kuo Lee, et al.
Published: (2021-07-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in Chinese elderly patients with acute coronary syndrome
by: Wang HD, et al.
Published: (2016-07-01)

Clopidogrel or ticagrelor alongside dabigatran in acute coronary syndrome and indication for NOAC: A study rationale
by: Luijkx, J., et al.
Published: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6a7j0k8bcbtiiam14cjjkd5rdg